Escape of HIV-1 Envelope Glycoprotein from Restriction of Infection by IFITM3

被引:12
作者
Drouin, Aurelie [1 ,2 ]
Migraine, Julie [1 ,2 ]
Durand, Marie-Alice [1 ,2 ]
Moreau, Alain [1 ,2 ]
Burlaud-Gaillard, Julien [1 ,2 ,3 ]
Beretta, Maxime [1 ,2 ,4 ]
Roingeard, Philippe [1 ,2 ,3 ]
Bouvin-Pley, Melanie [1 ,2 ]
Braibant, Martine [1 ,2 ]
机构
[1] Univ Tours, Tours, France
[2] CHRU Tours, INSERM, U1259, Tours, France
[3] CHRU Tours, Plateforme IBiSA Microscopie Elect, Tours, France
[4] Inst Pasteur, Dept Immunol, Lab Humoral Immunol, Paris, France
关键词
IFITM3; envelope glycoprotein; human immunodeficiency virus; restriction factor; IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODY; INFLUENZA-A VIRUS; WEST NILE VIRUS; PROTEINS; BROAD; NEUTRALIZATION; GP41; INHIBITION; RESISTANCE;
D O I
10.1128/JVI.01994-20
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that reduces HIV-1 infectivity by an incompletely understood mechanism. We show here that viruses differing only in the envelope glycoprotein (Env) expressed on their surface have different sensitivities to IFITM3. Measurements of the sensitivity of viruses to neutralizing antibodies showed that IFITM3 increased the sensitivity of IFITM3-sensitive viruses to PG16, which targets the V1V2 loop, suggesting that IFITM3 promotes exposure of the PG16 epitope of IFITM3-sensitive viruses. Exchanges of V1V2 loops between the Env proteins of sensitive and resistant viruses revealed that V1V2 and V3 act together to modulate viral sensitivity to IFITM3. Coimmunoprecipitation experiments showed that IFITM3 interacted with both the precursor (gp160) and cleaved (gp120) forms of Env from IFITM3-sensitive viruses but with only the precursor (gp160) form of Env from IFITM3-resistant viruses. This finding suggests that the interaction between the Env protein of resistant viruses and IFITM3 was inhibited once Env had been processed in the Golgi apparatus. This hypothesis was supported by immunofluorescence experiments, which showed a strong colocalization of IFITM3 with Env of sensitive viruses, but only weak colocalization with Env of resistant viruses on the plasma membrane of virus-producing cells. Together, these results indicate that IFITM3 interacts with Env, inducing conformational changes that may decrease viral infectivity. This antiviral action is, nevertheless, modulated by the nature of Env, in particular its V1V2 and V3 loops, which after maturation may be able to escape this interaction. IMPORTANCE Interferon-induced transmembrane protein 3 (IFITM3) is a cellular factor that reduces HIV-1 infectivity by an incompletely understood mechanism. This study aimed to elucidate the role of the HIV-1 envelope glycoprotein (Env) in determining viral susceptibility to IFITM3. We found that viruses differing only in Env expressed on their surface had different sensitivities to IFITM3. By comparing the Env proteins of viruses that were highly sensitive or resistant to IFITM3, we obtained new insight in the mechanisms by which HIV-1 escapes this protein. We showed that IFITM3 interacts with the Env protein of sensitive viruses in virion-producing cells, inducing conformational changes that may decrease viral infectivity. However, this antiviral action is modulated by the nature of Env, particularly the V1V2 and V3 loops, which may be able to escape this interaction after processing in the Golgi apparatus.
引用
收藏
页数:18
相关论文
共 50 条
[21]   A novel domain within the CIL regulates egress of IFITM3 from the Golgi and reveals a regulatory role of IFITM3 on the secretory pathway [J].
Zhong, Li ;
Song, Yuxin ;
Marziali, Federico ;
Uzbekov, Rustem ;
Xuan-Nhi Nguyen ;
Journo, Chloe ;
Roingeard, Philippe ;
Cimarelli, Andrea .
LIFE SCIENCE ALLIANCE, 2022, 5 (07)
[22]   IFITM3 Reduces Retroviral Envelope Abundance and Function and Is Counteracted by glycoGag [J].
Ahi, Yadvinder S. ;
Yimer, Diborah ;
Shi, Guoli ;
Majdoul, Saliha ;
Rahman, Kazi ;
Rein, Alan ;
Compton, Alex A. .
MBIO, 2020, 11 (01)
[23]   Functional Heterogeneity of Mammalian IFITM Proteins against HIV-1 [J].
Marziali, Federico ;
Delpeuch, Mathilde ;
Kumar, Anuj ;
Appourchaux, Romain ;
Dufloo, Jeremy ;
Tartour, Kevin ;
Etienne, Lucie ;
Cimarelli, Andrea .
JOURNAL OF VIROLOGY, 2021, 95 (18)
[24]   Interferon-Inducible Transmembrane Protein 3 (IFITM3) Restricts Rotavirus Infection [J].
Pang, Zhaoxia ;
Hao, Pengfei ;
Qu, Qiaoqiao ;
Li, Letian ;
Jiang, Yuhang ;
Xiao, Shuqi ;
Jin, Ningyi ;
Li, Chang .
VIRUSES-BASEL, 2022, 14 (11)
[25]   Rhesus macaque IFITM3 gene polymorphisms and SIV infection [J].
Winkler, Michael ;
Gaertner, Sabine ;
Wrensch, Florian ;
Krawczak, Michael ;
Sauermann, Ulrike ;
Poehlmann, Stefan .
PLOS ONE, 2017, 12 (03)
[26]   mTOR inhibitors lower an intrinsic barrier to virus infection mediated by IFITM3 [J].
Shi, Guoli ;
Ozog, Stosh ;
Torbett, Bruce E. ;
Compton, Alex A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (43) :E10069-E10078
[27]   IFITM3: How genetics influence influenza infection demographically [J].
Wellington, Dannielle ;
Laurenson-Schafer, Henry ;
Abdel-Haq, Adi ;
Dong, Tao .
BIOMEDICAL JOURNAL, 2019, 42 (01) :19-26
[28]   Glycosylation in HIV-1 envelope glycoprotein and its biological implications [J].
Ho, Yung Shwen ;
Saksena, Nitin K. .
FUTURE VIROLOGY, 2013, 8 (08) :783-800
[29]   Structural basis of transmembrane coupling of the HIV-1 envelope glycoprotein [J].
Piai, Alessandro ;
Fu, Qingshan ;
Cai, Yongfei ;
Ghantous, Fadi ;
Xiao, Tianshu ;
Shaik, Md Munan ;
Peng, Hanqin ;
Rits-Volloch, Sophia ;
Chen, Wen ;
Seaman, Michael S. ;
Chen, Bing ;
Chou, James J. .
NATURE COMMUNICATIONS, 2020, 11 (01)
[30]   Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation [J].
Tran, Erin E. H. ;
Borgnia, Mario J. ;
Kuybeda, Oleg ;
Schauder, David M. ;
Bartesaghi, Alberto ;
Frank, Gabriel A. ;
Sapiro, Guillermo ;
Milne, Jacqueline L. S. ;
Subramaniam, Sriram .
PLOS PATHOGENS, 2012, 8 (07) :37